SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Lal PathLabs submits board meeting intimation

31 Jul 2024 Evaluate
Dr. Lal PathLabs has informed that a meeting of the Board of Directors is scheduled to be held on Wednesday, August 7, 2024 to consider and approve the Un-audited (Standalone & Consolidated) Financial Results of the Company for the Quarter ended June 30, 2024 and to consider recommending Interim Dividend, if any, on the Equity Shares of the Company for the Financial Year 2024-25. Further, in continuation to our letter dated June 26, 2024 and in line with the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's Code for Prevention of Insider Trading, the Trading Window for dealing in Securities of the Company is closed and shall re-open after 48 hours from the declaration of the aforesaid Financial Results.

The above information is a part of company’s filings submitted to BSE.

Dr. Lal Pathlabs Share Price

1403.15 -8.60 (-0.61%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×